This st udy will look at the prostate-specific antigen (PSA) levels in patients with chronic SCI and compare that to age-matched able-bodied individuals. In addition, it will look at whether or not the following factors affect PSA levels: age, length of injury, level of injury, severity ...
had the largest estimated PSA effect size (16%, 95% CI=11%–20%).COMMD3plays a role in the NF-κB pathway39and is often involved in protein-fusion products withBMI1, a polycomb ring finger oncogene overexpressed in PCa40. The neighboring gene,SPAG6,is a sperm-associated antigen41....
Recommended to those with low Gleason and PSA levels, and nonpalpable tumors. Monitoring and Care Expectant therapy includes regular visits to a doctor for prostate specific antigen (PSA) tests and digital rectal exams. Watchful Waiting Outcomes ...
On the right to the cladogram, plasma total prostate specific antigen (PSA) levels are placed on the timeline in dark gray, together with corresponding percent free PSA values in light gray when available. GP5 received dutasteride and finasteride for symptoms of benign prostatic hyperplasia during...
Joshi N, Bissada NF, Bodner D, Maclennan GT, Narendran S, Jurevic R, Skillicorn R. Association between periodontal disease and prostate-specific antigen levels in chronic prostatitis patients. J Periodontol 2010; 81(6): 864–869 CASPubMedGoogle Scholar ...
Mann–Whitney U test was used to compare PI-RADS assessment category, QCE, CER, tumor size, Fig. 1 A flow chart in this study workflow. PSA: prostate-specific antigen; PC: prostate cancer; DCE-MRI: dynamic contrast-enhanced MRI; DWI: diffusion-weighted imaging; PZ: peripheral ...
Logically speaking, combined with serum prostate-specific antigen testing, the PPS theory could also be generalized to older type-III prostatitis patients without BPH and prostate tumors. Limitations of the study The limitations of this study must be mentioned. Firstly, the clinical application of ...
Diagnostic yield of repeated transrectal ultrasound-guided biopsies stratified by specific histopathologic diagnoses and prostate-specific antigen levels Urology, 47 (1996), pp. 347-352 View PDFView articleView in ScopusGoogle Scholar 10 W.J Ellis, M.K Brawer Repeat prostate needle biopsy: who needs...
Long-term data indicate that 30-40% of these patients experience rising prostate-specific antigen (PSA) levels after RP, indicating continued survival of prostate cells. A significant rise in PSA level after RP may be termed a “biochemical failure” (BF), “biochemical recurrence”, or “...
Sunnybrook researchers developed and validated the nomogram with 3,108 Canadian men including a subset of 408 volunteers with normal PSA (prostate specific antigen) levels who underwent a prostate biopsy. Of the 3,108 men, 42 per cent were diagnosed with prostate cancer. The nomogram was shown ...